OXSI-2 is a potent and cell-permeable Syk inhibitor used to inhibit spleen tyrosine kinase (Syk)-mediated signaling pathways, with applications in the study of inflammation, inflammasome activation, pyroptosis, GPVI signaling, and related tyrosine kinase-dependent processes.